Pulmonary Arterial Hypertension Market To Reach USD 12.2 Billion By 2032 | DataHorizzon Research Fort Collins, Colorado, May 10, 2024 (GLOBE NEWSWIRE) -- The use of novel therapies and treatment strategies has encouraged significant developments for PAH. The global market for pulmonary...

Pulmonary Arterial Hypertension (PAH) Market to Hit US$ 12.7 Billion by 2033: Fact.MR Report Rockville , Aug. 20, 2023 (GLOBE NEWSWIRE) -- Expanding at a CAGR of 5.4% from 2023 to 2033, the global pulmonary arterial hypertension market is forecasted to end up at a valuation of US$ 12.7...

Pulmonary Arterial Hypertension Market Size Worth US$ 13.7 Bn and Grow at a CAGR of 6.2% From (2022-2032) - Persistence Market Research Report New York, Jan. 24, 2023 (GLOBE NEWSWIRE) -- The Pulmonary Arterial Hypertension Market revenues was estimated at US$ 7.1 Bn in 2021 and is anticipated to grow at a CAGR of 6.2% from 2022-2032,...

Pulmonary Arterial Hypertension Market to Garner USD 12 Billion by 2031, Claims Allied Market Research Portland, OR, Nov. 15, 2022 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the global pulmonary arterial hypertension market generated $7.2 billion in 2021, and is...

Pulmonary Arterial Hypertension Market to reach a valuation of US$5.19 Bn by 2020, Says TMR Albany, NY, July 24, 2018 (GLOBE NEWSWIRE) -- According to TMR, the global pulmonary arterial hypertension therapeutics market is expected to reach a valuation of US$ 5.19 bn by the end of 2020. The...